biosimilar

Dr Reddy’s and TR-Pharm in agreement

TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey

Generic opportunities outweigh challenges emanating across emerging markets: ICRA

Supported by acquisitions, geographic expansion and steadily expanding product portfolio, the top-10 pharma companies from India have achieved a CAGR of 21 per cent in revenues from emerging markets over the past five years

Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)

Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative condition of the eyes in the elderly

Syngene seeks approval for IPO, files DRHP

Offer allows Biocon to monetise its shareholding in Syngene

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

US Stock Market

View All

 

Stock Market

Most Read

Advertisement

Top News

Advertisement

Related Articles